CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −51,488 | 0 | ||
| 2022-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Option exercise · Restricted Share Units | −18,905 | 18,906 | ||
| 2022-03-04 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +140,750 | 140,750 | ||
| 2022-03-04 | Drape Eric Executive VP Global Operations | Option exercise | +32,518 | 78,348 | ||
| 2022-03-04 | Drape Eric Executive VP Global Operations | Sale | −17,157 | $7.48 | $128K | 61,191 |
| 2022-03-04 | Drape Eric Executive VP Global Operations | Option exercise | +11,940 | 73,131 | ||
| 2022-03-04 | Drape Eric Executive VP Global Operations | Sale | −6,301 | $7.48 | $47K | 66,830 |
| 2022-03-04 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −32,518 | 0 | ||
| 2022-03-04 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units | −11,940 | 11,940 | ||
| 2022-03-04 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +134,048 | 134,048 | ||
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Option exercise | +37,939 | 137,396 | ||
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Option exercise | +13,930 | 151,326 | ||
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Sale | −3,904 | $7.48 | $29K | 147,422 |
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −37,939 | 0 | ||
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Option exercise · Restricted Share Units | −13,930 | 13,931 | ||
| 2022-03-04 | Dethlefs Sven EVP, North America Commercial | Grant or award · Restricted Share Units | +154,155 | 154,155 | ||
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise | +15,920 | 36,200 | ||
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Sale | −15,920 | $7.48 | $119K | 20,280 |
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise | +43,358 | 63,638 | ||
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Sale | −20,456 | $7.48 | $153K | 43,182 |
Page 39 of 76 · 1,517 trades